Tag - pfizer

 
 

PFIZER

Japan Times
JAPAN
Jan 16, 2021
Japan seeks mid-February Pfizer vaccine approval, minister says
'We need to do it as fast as possible,” health minister Norihisa Tamura said Friday. 'If all goes well, I would like to see the approval in about mid-February.”
Japan Times
WORLD / Science & Health
Dec 23, 2020
How vaccine-makers are preparing for mutant coronavirus strains
Drugmakers have said they could reset the COVID-19 shot to counter a new strain within just six weeks.
Japan Times
WORLD
Dec 22, 2020
EU clears Pfizer COVID-19 vaccine for first inoculations
Preparations for the vaccine roll-out come as the identification of a highly infectious new strain of the coronavirus in Britain caused chaos across the region.
Japan Times
JAPAN / Science & Health
Dec 18, 2020
Pfizer first drugmaker to seek COVID-19 vaccine approval in Japan
Officials said the approval would be made 'a top priority in the screening process' once the firm submits data from an ongoing clinical trial specific to Japan, expected in February.
Japan Times
WORLD
Dec 15, 2020
A weapon to ‘win the war’: U.S. hospitals get initial coronavirus shots
The arrival of the Pfizer-BioNTech vaccine offers a glimmer of hope amid a pandemic that has already seen almost 300,000 Americans die.
Japan Times
COMMENTARY / World
Dec 12, 2020
Vaccines alone aren’t enough to beat COVID-19
While an effective vaccine is sure to help, a safe oral antiviral drug would truly step up efforts to fight the pandemic.
Japan Times
WORLD / Science & Health
Dec 10, 2020
U.K. issues anaphylaxis warning on Pfizer vaccine after adverse reactions
Britain began mass vaccinating its population on Tuesday, part of a global drive that poses one of the biggest logistical challenges in peacetime history.
Japan Times
WORLD
Dec 6, 2020
With Pfizer's COVID-19 shot, Britain prepares for world-first vaccine rollout
Britain gave emergency use approval for the vaccine last week — jumping ahead in the global race to begin the most crucial mass inoculation program in history.
Japan Times
WORLD / Science & Health
Dec 4, 2020
Pfizer scaled back COVID-19 vaccine output targets earlier this year
Pfizer Inc. scaled back its COVID-19 production targets earlier this year after the drugmaker ran into difficulties securing all the materials it needs to produce the shots at a large scale.
Japan Times
WORLD / Science & Health
Dec 3, 2020
Why the U.K. approved a COVID-19 vaccine first
Doses of the Pfizer-BioNTech vaccine will be injected starting next week, the government said.
Japan Times
WORLD / Science & Health
Nov 29, 2020
U.K. poised to be first to approve Pfizer-BioNTech COVID-19 vaccine
The U.K. is poised to become the first country to approve Pfizer Inc. and BioNTech SE’s COVID-19 vaccine, ahead of a long line of countries waiting for protection from the coronavirus.
Japan Times
JAPAN / Science & Health
Nov 25, 2020
Not so fast, Japan experts say, as COVID-19 vaccines raise hopes
Medical experts say long-term safety and efficacy concerns remain as the vaccines are developed in record-setting time.
Japan Times
COMMENTARY
Nov 22, 2020
Pfizer vaccine's safety milestone is just the beginning
As new vaccines look set for regulatory approval, managing the follow-up on adverse drug reactions will be critical for any vaccination program to be successful.
Japan Times
COMMENTARY / World
Nov 21, 2020
Why Moderna’s vaccine win is a giant leap against pandemics
Alongside recent results from Pfizer, the news that a vaccine is proving effective is a great step forward.
Japan Times
WORLD / Science & Health
Nov 19, 2020
Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'
Final trial results showed the vaccine had a 95% success rate and no serious side effects, the drugmakers said.
Japan Times
WORLD / Science & Health
Nov 18, 2020
Pfizer reaches safety milestone for COVID-19 vaccine, CEO says
Pfizer Inc. Chief Executive Officer Albert Bourla said that a key safety milestone had been reached in the study of its COVID-19 vaccine, and the drugmaker is now preparing to seek an emergency-use authorization from U.S. regulators.
Japan Times
WORLD / Science & Health / FOCUS
Nov 18, 2020
How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine
Researchers were asked to tackle something that had never been done before: design a vaccine to stop a pandemic in its tracks in less than a year.
Japan Times
WORLD / Science & Health
Nov 17, 2020
Moderna’s COVID-19 vaccine: What you need to know
Coming a week after similar news from Pfizer and BioNTech, Moderna's announcement offered more hope that there's going to be a way out of the pandemic.
Japan Times
WORLD / Science & Health
Nov 17, 2020
How the Moderna and Pfizer coronavirus vaccines stack up
The encouraging late-stage trial results from Pfizer Inc. and Moderna Inc. set a high bar for rivals that are expected to follow soon with their own pivotal reports.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?